Pompe disease, or glycogen storage disease type II, is a rare autosomal recessive disorder caused by mutations in the gene that encodes for alpha-glucosidase. Presentation in infancy is associated with respiratory failure, cardiomyopathy, and severe muscle weakness. Juvenile- or adult-onset cases typically present with proximal muscle weakness and are associated with respiratory insufficiency or exertional dyspnea. Treatment, until recently, was focused on supportive measures, and infants diagnosed with Pompe disease usually died within the first year of life. The recent development of recombinant alpha-glucosidase has dramatically improved the life expectancy and quality of life of infantile-onset disease with improvements in respiratory and motor function observed in juvenile- or adult-onset cases. This review focuses on the presentation, pathogenesis, diagnosis, and treatment recommendations for Pompe disease in this new era of enzyme replacement therapy.
"The most severe infantile form is devastating and rapidly fatal with cardiomyopathy, hypotonia, feeding difficulties and hepatomegaly, whereas the milder adult form is mainly characterized by proximal muscle weakness and respiratory involvement   . The introduction of enzyme replacement therapy (ERT) with recombinant human GAA has substantially modified the course of the disease, especially in infants , but preliminary studies also suggest clinical benefits among adults  . "
[Show abstract][Hide abstract] ABSTRACT: Pompe disease is an inherited metabolic disorder caused by α-glycosidase deficiency. The adult onset form is mainly characterized by progressive proximal muscle weakness and respiratory dysfunction. The aim of the present study is to evaluate body composition in adult patients before and after enzyme replacement therapy (ERT). Body composition was examined at baseline by means of dual x-ray absorptiometry (DXA) in nine adult patients and after different time periods in six of them who received ERT. Total BMD (bone mineral density) was initially mildly decreased in two patients, while femoral neck BMD was decreased in five patients. On the other hand fat mass was increased in the majority of patients, while body mass index (BMI) was high in four. ERT administration did not seem to induce obvious BMD changes in any patient. Conclusively, the greater femoral neck BMD involvement may be attributed to the lower mechanical load applied by the selectively weakened muscles, whereas the increased fat mass may be the result of metabolic and nutritional derangement.
[Show abstract][Hide abstract] ABSTRACT: The manufacture of six sigma quality high density interconnects by
use of tin-lead solder flip chip bumps has prompted the application of
computational analysis tools to assist in establishing the significance
of variations of the bumps. Analytical model results and finite element
predictions of solder joint geometry were compared to measured data. The
solder geometric data and independently established component and
substrate warpage were combined to calculate interconnect
Thermal and Thermomechanical Phenomena in Electronic Systems, 1998. ITHERM '98. The Sixth Intersociety Conference on; 06/1998
[Show abstract][Hide abstract] ABSTRACT: An approximate UTD coefficient has been extended for the junction
between two material plates. The present development has been carried
out for plate angles greater than 60° on the source side. However,
the method can be extended to angles less than 60° in a similar
fashion. The source should not be located too close to the surface to
avoid surface waves. Reasonable comparisons between this approximate
solution and moment method solutions are obtained
Antennas and Propagation Society International Symposium, 1998. IEEE; 07/1998
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.